Egyesült Államok - angol - NLM (National Library of Medicine)

good sense - (in each effervescent tablet), anhydrous citric acid 1000 mg, aspirin 325 mg (nsaid)*, sodium bicarbonate (heat-treated) 1916 mg, *nonsteroidal anti-inflammatory drug - anhydrous citric acid 1000 mg ................................ antacid aspirin 325 mg (nsaid)* ..........................................pain reliever sodium bicarbonate (heat-treated) 1916 mg ...........antacid *nonsteroidal anti-inflammatory drug uses for the temporary relief of ■ heartburn, acid indigestion and sour stomach when accompanied with headache or body aches and pains ■ upset stomach with headache from overindulgence in food or drink ■ headache, body aches and pain alone ■ if you have ever had an allergic reaction to any other pain reliever/fever reducer ■ if you have ever had an allergic reaction to this product or any of its ingredients. ■ stomach bleeding warning applies to you ■ you have a history of stomach problems, such as heartburn ■ you have high blood pressure, heart disease, liver cirrhosis, or kidney disease ■ you are taking a diuretic ■ you have asthma ■ you have a sodium-restricted diet ■ presently taking a prescription drug. antacids may interact with certain prescription drugs

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - paracetamol - effervescent tablet - 500mg

Egyesült Államok - angol - NLM (National Library of Medicine)

h. e. butt grocery company - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - aspirin 325 mg (nsaid)* . . . . . . . . . . . . . . . . . . . . . .pain reliever citric acid 1000 mg . . . . . . . . . . . . . . . . . . . . . .. . . . antacid sodium bicarbonate (heat-treated) 1916 mg . . . . . . antacid *nonsteroidal anti-inflammatory drug uses for the temporary relief of ■ heartburn, acid indigestion and sour stomach when accompanied by headache or body aches and pains ■ upset stomach with headache from overindulgence in food or drink ■ pain alone (headaches or body aches and pains) do not use ■ if you have ever had an allergic reaction to any other pain reliever/fever reducer ■ if you are allergic to aspirin ■ if overly full from food or drink. ask a doctor if severe stomach pain occurs after taking this product. ask a doctor before use if ■ stomach bleeding warning applies to you ■ you have a history of stomach problems, such as heartburn ■ you have high blood pressure, heart disease, liver cirrhosis, or kidney disease ■ you are taking a diuretic ■ you have a sodium-restricted diet

Málta - angol - Medicines Authority

bayer s.p.a. viale certosa, 130 - 20156, milano, italy - ascorbic acid, acetylsalicylic acid - effervescent tablet - ascorbic acid 240 mg acetylsalicylic acid 400 mg - analgesics

Írország - angol - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - acetylsalicylic acid - effervescent tablet - 500 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - aspirin - effervescent tablet - 500mg

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - aspirin - effervescent tablet - 300mg

Írország - angol - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - paracetamol - effervescent tablet - 1000 milligram(s) - anilides; paracetamol

Írország - angol - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - paracetamol - effervescent tablet - 500 milligram(s) - anilides; paracetamol

Egyesült Államok - angol - NLM (National Library of Medicine)

avkare - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin, usp is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis and nasal polyps. aspirin, usp may cause severe urticaria, angioedema or bronchospasm. do not use aspirin, usp in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects, pregnancy category d. [see warnings and precautions (5.4)]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pregnancy [see warnings and precautions (5.4)] , avoid aspirin and extended-release dipyridamole in the third trimester of pregnancy and during labor and delivery. both dipyridamole and aspirin are excreted in human milk. exercise caution when aspirin and extended-release dipyridamole capsules are administered to a nursing woman. safety and effectiveness of aspirin and extended-release dipyridamole in pediatric patients have not been studied. due to the aspirin component, use of this product in the pediatric population is not recommended [see contraindications (4.3)] . of the total number of subjects in esps2, 61 percent were 65 and over, while 27 percent were 75 and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out [see clinical pharmacology (12.3)] . aspirin and extended-release dipyridamole has not been studied in patients with hepatic or renal impairment. avoid using aspirin containing products, such as aspirin and extended-release dipyridamole in patients with severe hepatic or severe renal (glomerular filtration rate < 10 ml/min) dysfunction [see  warnings and precautions (5.2,  5.3) and clinical pharmacology (12.3)] .